Business ❯Pharmaceutical Companies

AstraZeneca

Drug Manufacturers Partnerships Lung Cancer Treatment Beyfortus Drug Development RSV Drug Studies Boehringer Ingelheim Safety Profile

AstraZeneca Targets $80 Billion Revenue by 2030 with 20 New Medicines

The pharmaceutical giant aims to nearly double its revenue through a strong focus on oncology, biopharmaceuticals, and rare diseases.

First US Lawsuit Filed Against AstraZeneca by Vaccine Trial Participant

AstraZeneca Acknowledges Rare Blood Clot Risk with Covishield Vaccine

AstraZeneca Caps Inhaler Costs at $35 Amid Political Pressure

AstraZeneca Projects Strong Growth in 2024 Despite COVID-19 Sales Dip